What is Heart-on-a-chip Market Scope?
Increasing Focus on Drug Discovery Activities will help to boost the global market in the forecasted period. A heart on a chip is a cell culturing microfluidic device to create a highly controlled environment to mimic the natural habitat of the heart cells. A heart-on-chip is a microfluidic chip reproducing the mechanisms of a heart, in order to test medicine quickly and observe the reaction of heart cells. Great care is given to mimic the mechanics of a heart in an artificial structure, lined with live heart cells. According to the World Health Organization, cardiovascular diseases are the leading cause of death worldwide. In 2008, there were an estimated 17.3 million deaths due to cardiovascular diseases. This means that around 30% of the people who died in 2008 died because of heart failure. Moreover, cardiotoxicity is one of the leading causes of drug withdrawals.
The Heart-on-a-chip market study is being classified by Type (Children Heart-on-a-chip and Adult Heart-on-a-chip), by Application (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Other End Users) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Heart-on-a-chip market throughout the predicted period.
Mimetas (Netherlands), Emulate (United States), InSphero (Switzerland), Ascendance Bio (United States), CN Bio (United Kingdom), TissUse (Germany), Kirkstall (United Kingdom), HUREL (HUREL) (United States), SynVivo (United States) and AxoSim (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Nortis (United States).
Analyst at AMA have segmented the market study of Global Heart-on-a-chip market by Type, Application and Region.
On the basis of geography, the market of Heart-on-a-chip has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2019. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.
Influencing Market Trend
- Technological Advancements and New Products Launches
- Growing Number of Partnerships and Collaborations Between Pharmaceutical Companies and Heart-on-Chips Manufacturers
- Significant Increase in Research Funding and Venture Capital Investments for the Development of Heart-on-Chips
- Increasing Focus on Drug Discovery Activities
- Application of Heart-on-Chips in Oncology Research
- Issues Related to the Incorporation of Organs-on-Chips Technologies Into Existing Workflows
- The complexity of Organs-on-Chips Models
- The dearth of Skilled Professionals
Key Target AudienceGovernment Regulatory Bodies, Government research Organization, Private Research Organization and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.
Frequently Asked Questions (FAQ):
1. At what growth rate would the Heart-on-a-chip market expands?
The Global Heart-on-a-chip market is expected to see a growth of % during projected year 2019 to 2026.
2. Who are the prominent players of the Global Heart-on-a-chip market?
The prominent players of Global Heart-on-a-chip market are Mimetas (Netherlands), Emulate (United States), InSphero (Switzerland), Ascendance Bio (United States), CN Bio (United Kingdom), TissUse (Germany), Kirkstall (United Kingdom), HUREL (HUREL) (United States), SynVivo (United States) and AxoSim (United States), to name a few.
3. What are the top priorities to focus for Heart-on-a-chip marketís growth?
In this highly competitive & fast evolving Heart-on-a-chip industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.